INFINITY PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2011 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Infinity Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2011 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 89.9M shares, a 0.81% increase year-over-year.
  • Infinity Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 89.2M shares, a 4.27% increase from 2021.
  • Infinity Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 85.6M shares, a 43% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 89.9M +724K +0.81% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 89.4M +258K +0.29% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 89.2M +3.65M +4.27% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 89.4M +625K +0.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 89.2M +500K +0.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 89.2M +13.4M +17.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 85.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 88.8M +28.3M +46.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 88.7M +31.2M +54.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 75.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2020 60.5M +3.48M +6.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 57.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q3 2019 57M -610K -1.06% Jul 1, 2019 Sep 30, 2019 10-Q 2019-10-30
Q3 2018 57.6M +7M +13.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q3 2017 50.6M +1.05M +2.12% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 50.5M +1.02M +2.06% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-03
Q4 2016 50.1M +871K +1.77% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 49.6M -181K -0.36% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 49.4M +364K +0.74% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 49.3M +401K +0.82% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 49.2M +439K +0.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 49.8M +29.6K +0.06% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 49.1M +532K +1.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 48.9M +591K +1.22% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 48.8M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 49.7M +1.68M +3.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-23
Q2 2014 48.5M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-23
Q1 2014 48.3M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-23
Q3 2013 48.1M +12.9M +36.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q4 2012 40.9M Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 35.2M +8.51M +31.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 27.1M Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 26.8M Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q3 2011 26.7M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.